phrykt

Equillium, Inc. (EQ): who owns it and who trades it

As of Nov 16, 2026, EQ insiders reported 18 open-market sales worth $2.4M and no purchases in the last 12 months, with 70% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christine Zedelmayer (Vice president), with $1.5M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Equillium

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns EQ

60 funds and institutions reported EQ shares worth $133M at the end of Q2 2026, about 66% of the company. The largest holder is Jupiter Topco LLC with 10.3%.

Funds and institutions (13F) 66%Everyone else 34%

10 largest owners, by share of the company

Jupiter Topco LLC10.3%
Decheng Capital LLC7.0%
Affinity Asset Advisors, LLC6.5%
ADAR1 Capital Management, LLC5.9%
Aberdeen Group plc5.7%
Woodline Partners LP5.5%
Ra Capital Management, L.P.4.9%
Stempoint Capital LP3.2%
Vanguard Capital Management LLC2.9%
Eversept Partners, LP2.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Jupiter Topco LLC6.49M10.27%$20.7MNew
Decheng Capital LLC4.45M7.03%$14.2MNo change
Affinity Asset Advisors, LLC4.10M6.48%$13.1M+234%
ADAR1 Capital Management, LLC3.76M5.94%$12M+1%
Aberdeen Group plc3.63M5.74%$11.6M+8%
Woodline Partners LP3.50M5.54%$11.2MNo change
Ra Capital Management, L.P.3.10M4.90%$9.9MNo change
Stempoint Capital LP2.02M3.19%$6.5MNew
Vanguard Capital Management LLC1.82M2.88%$5.8M+2%
Eversept Partners, LP1.52M2.41%$4.9M+1%
Adage Capital Partners Gp, L.l.c.1.39M2.20%$4.4M-74%
Renaissance Technologies LLC637,6171.01%$2M-3%
Exome Asset Management LLC552,9560.87%$1.8MNew
DG Capital Management, LLC463,3960.73%$1.5MNew
Diadema Partners LP400,2820.63%$1.3M-8%
Geode Capital Management, LLC381,1750.60%$1.2M+1%
Balyasny Asset Management L.P.344,4090.54%$1.1M-79%
Tudor Investment Corp Et Al320,1000.51%$1M+1493%
Ikarian Capital, LLC303,5550.48%$971KNo change
BlackRock, Inc.285,4090.45%$913K+123%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, EQ insiders reported $0 of open-market purchases and $2.4M of sales. 70% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$2.4M
18 trades, 3 people
Sales under a 10b5-1 plan
70%
Share of sale value
Latest trade
Jun 5, 2026
Filed Jun 5, 2026

Purchases and sales by month

$766K$766KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jun 5, 2026Christine ZedelmayerVice presidentSale plan14,584$2.93$42.7KForm 4
Jun 5, 2026Stephen ConnellyPresidentSale30,975$2.94$91.1KForm 4
Jun 4, 2026Stephen ConnellyPresidentSale200,000$3.16$632KForm 4
May 28, 2026Penny TomPrincipal Accounting OffSale plan65,000$2.95$192KForm 4
May 28, 2026Christine ZedelmayerVice presidentSale plan200$2.71$542Form 4
May 28, 2026Christine ZedelmayerVice presidentSale plan55,604$2.70$150KForm 4
May 28, 2026Christine ZedelmayerVice presidentSale plan30,208$2.98$90KForm 4
May 27, 2026Christine ZedelmayerVice presidentSale plan9,821$2.70$26.5KForm 4
Mar 13, 2026Christine ZedelmayerVice presidentSale plan120,312$2.50$301KForm 4
Mar 9, 2026Christine ZedelmayerVice presidentSale plan181,219$2.00$362KForm 4
Feb 19, 2026Christine ZedelmayerVice presidentSale plan76,562$1.74$133KForm 4
Feb 19, 2026Christine ZedelmayerVice presidentSale plan109,375$1.78$195KForm 4
Jan 8, 2026Penny TomPrincipal Accounting OffSale plan6,533$1.29$8.4KForm 4
Dec 23, 2025Christine ZedelmayerVice presidentSale plan100,000$1.50$150KForm 4
Dec 15, 2025Christine ZedelmayerVice presidentSale plan11,900$1.31$15.6KForm 4
Dec 12, 2025Christine ZedelmayerVice presidentSale plan23,804$1.34$31.9KForm 4
Nov 25, 2025Christine ZedelmayerVice presidentSale plan7,998$0.95$7.6KForm 4
Nov 25, 2025Christine ZedelmayerVice presidentSale plan100$0.98$98Form 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Christine ZedelmayerSr. Vice President and COO–$1.5MJun 5, 2026
Stephen ConnellyPresident and CSO–$723KJun 5, 2026
Penny TomPrincipal Accounting Officer–$200KMay 28, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

EQ short interest

Moderate short interest. 9.3% of EQ shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went up 106%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 5.92M EQ shares were sold short, 9.3% of the shares outstanding, up 4.7% from the report before. At the average daily volume of 622,382 shares, buying them all back would take about 9.5 trading days (days to cover).

Shares short, % of all shares

9.34%May 15Oct 3010.1%

Days to cover

9.5May 15Oct 3016.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20265.92M9.34%+5%622,3829.5
Oct 15, 20265.66M8.92%+2%515,90311.0
Sep 30, 20265.54M8.74%+1%925,6946.0
Sep 15, 20265.50M8.67%+2%365,96515.0
Aug 31, 20265.37M8.47%-3%409,91713.1
Aug 14, 20265.53M8.73%+2%553,60510.0
Jul 31, 20265.42M8.57%-3%457,58011.8
Jul 15, 20265.57M8.81%+9%1.23M4.5
Jun 30, 20265.11M8.09%+9%768,2846.7
Jun 15, 20264.71M7.45%+31%1.52M3.1
May 29, 20263.61M5.70%+26%606,6186.0
May 15, 20262.87M4.54%+2%233,83212.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Equillium company events

Equillium filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 26, 2026.

  1. Oct 26, 2026AnnouncementOf this Current Report on Form 8-K is incorporated by reference under this Item 3.02. Filing
  2. Oct 5, 2026AnnouncementEquillium, Inc. (the Company) announced that the Company has received Human Research Ethics Committee approval and clearance from the Therapeutic Goods Administration in Australia under the Clinical Trial Notification scheme for its Phase 1 clinical trial of EQ504. Filing
  3. Aug 13, 2026ResultsReleased financial results. Filing
  4. May 29, 2026VoteReported shareholder vote results. Filing
  5. May 13, 2026ResultsReleased financial results. Filing
  6. Mar 25, 2026ResultsReleased financial results. Filing
  7. Mar 13, 2026AgreementEquillium, Inc., a Delaware corporation, entered into a Securities Purchase Agreement with RA Capital Healthcare Fund, L.P., pursuant to which the Company agreed to sell and issue shares of the Company’s common stock, par value $0.0001, and a pre-funded warrant to purchase shares of Common Stock… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Equillium financials

Famous investors that hold EQ

4 of the 50 well-known investors we track reported holding EQ in their latest 13F filing. The largest position is Ken Griffin's, worth $963K.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026592,417$963K0.0%+494%
Jim Simons · Renaissance TechnologiesQ3 2026446,691$726K0.0%-30%
Paul Tudor Jones · Tudor Investment CorpQ3 2026243,383$395K0.0%-24%
Israel Englander · Millennium ManagementQ3 202620,819$33.8K0.0%-51%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named EQ in the last 120 days.

FiledHolderFormStake
Nov 16, 2026RA Capital Management, L.P.13G/A9.9%
Nov 16, 2026RA Capital Management, L.P.13G/A9.9%
Nov 13, 2026Affinity Asset Advisors, LLC13G/A4.1%
Nov 13, 2026Affinity Asset Advisors, LLC13G/A4.1%
Nov 12, 2026Adage Capital Management, L.P.13G/A5.9%
Nov 12, 2026Adage Capital Management, L.P.13G/A5.9%
Nov 4, 2026Aberdeen Group plc13G/A7.0%
Nov 4, 2026Aberdeen Group plc13G/A7.0%

Questions about Equillium, Inc. (EQ) stock

Who owns the most EQ stock?

The largest reported owner of Equillium, Inc. (EQ) is Jupiter Topco LLC, with 10.3% of the company. In total, 60 funds and institutions reported holding EQ at the end of Q2 2026, together about 66% of the shares. See the largest owners.

Are EQ insiders buying or selling?

In the last 12 months, EQ insiders reported no open-market purchases and 18 sales worth $2.4M. The latest trade was on Jun 5, 2026. See every trade.

What is the short interest in EQ?

As of Oct 30, 2026, 5.92M EQ shares were sold short, 9.3% of the shares outstanding, up 4.7% from the report before. At the average daily volume of 622,382 shares, buying them all back would take about 9.5 trading days (days to cover). See the history.

Which famous investors hold EQ?

4 of the 50 well-known investors we track reported EQ in their latest 13F filing, including Ken Griffin, Jim Simons, Paul Tudor Jones. The largest position is worth $963K. See all holders.

Executive pay

Equillium's chief executive was paid a total of $4.3M for the year ended Dec 31, 2025, up 522% from $684K the year before. In the last 12 months, Equillium's executives and directors bought no stock on the open market and sold $2.4M.

Chief executive, total pay$4.3MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$4.5MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2.4MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.